---

Diabetic Retinopathy — Stages & Classification

---

Classification Systems

1. ETDRS (modified Airlie House) classification — the international gold standard, used in clinical trials and screening programmes
2. Descriptive clinical categories — widely used in day-to-day practice

---

Stage-by-Stage Breakdown (ETDRS)

🔵 No Diabetic Retinopathy

• Normal fundus; no lesions visible
• Follow-up: 12 months

---

🟡 Non-Proliferative Diabetic Retinopathy (NPDR)

• Microaneurysms — earliest sign; saccular outpouchings of capillary walls, appear as tiny red dots
• Dot and blot haemorrhages — intraretinal blood from ruptured microaneurysms/capillaries
• Hard exudates — yellow, waxy lipid deposits from leaky vessels, often arranged in rings (circinate pattern)
• Cotton-wool spots (CWS) — white fluffy patches from nerve fibre layer infarcts; indicate ischaemia
• Venous beading — sausage-like irregularity of veins; marker of significant ischaemia
• IRMA (intraretinal microvascular abnormalities) — dilated, abnormal intraretinal vessels bypassing occluded capillaries; precursor to NVD/NVE

---

🟠 Proliferative Diabetic Retinopathy (PDR)

• NVD = new vessels on/within 1 disc diameter of the optic disc
• NVE = new vessels elsewhere in the retina
• NVI/NVA = neovascularisation of iris/angle → neovascular glaucoma risk

---

🔴 Advanced Diabetic Eye Disease

• Tractional retinal detachment — fibrovascular membranes contract and pull the retina
• Persistent/dense vitreous haemorrhage — obscures vision, may require vitrectomy
• Neovascular glaucoma (NVG) — rubeosis iridis (iris neovascularisation) → raised IOP

---

Diabetic Macular Oedema (DMO/DME)

• Clinically significant macular oedema (CSMO): retinal thickening or hard exudates at or threatening the foveal centre → treatment indication
• Detected clinically by slit-lamp biomicroscopy; confirmed by OCT
• Treatment: intravitreal anti-VEGF (first-line), focal/grid laser, or intravitreal steroids

---

Risk Factors for Progression

---

Treatment Summary by Stage

---

---

Biliary Tract Pathologies — Triads, Pentads, Signs & Management

---

🔷 QUICK REFERENCE: Classical Symptom Clusters

---

1. BILIARY COLIC

Pathophysiology

Classic Presentation (Triad)

Biliary Colic Triad:

1. Postprandial RUQ/epigastric pain — steady, dull or colicky, often radiating to right scapular tip or shoulder
2. Nausea and vomiting
3. Self-limited episodes — resolves within 30 min to 6 hours

Signs

• Mild RUQ tenderness on palpation, no guarding or rebound
• No fever, no jaundice, no leukocytosis (distinguishes from cholecystitis)
• Normal LFTs, normal lipase

Investigations

• Ultrasound: gallstones ± sludge, no wall thickening, no pericholecystic fluid

Management

• Analgesia: NSAIDs (ketorolac) or opioids
• Antiemetics
• IV fluids if unable to tolerate orally
• Elective laparoscopic cholecystectomy — definitive treatment
• Discharge with surgical outpatient referral if symptoms controlled

---

2. ACUTE CHOLECYSTITIS

Pathophysiology

Classic Presentation

Cholecystitis Triad:

1. RUQ pain — constant (unlike colic), radiating to right shoulder/scapula
2. Fever (38–39°C)
3. Nausea/vomiting

Signs

Investigations

• US: gallstones, GB wall thickening (>3–4 mm), pericholecystic fluid, sonographic Murphy's sign
• HIDA scan: non-visualisation of GB = cystic duct obstruction (most sensitive)
• Labs: leukocytosis (WBC >10,000 — absent in ~half), mild ↑ALT/AST/ALP/bilirubin; markedly elevated lipase → gallstone pancreatitis
• CT: if perforation, abscess, or emphysematous cholecystitis suspected

Tokyo Guidelines Severity Grading

Management

• IV fluids, NPO, analgesia (NSAIDs or opioids — neither delays surgery)
• Antibiotics: piperacillin-tazobactam 3.375 g IV q6h; or ampicillin-sulbactam 3 g IV q6h
  • Discontinue within 24 hours after complete cholecystectomy (source control)
  • Continue 4–7 days if perforation, abscess, or pericholecystic collections
• Definitive: laparoscopic cholecystectomy (gold standard)
• Percutaneous cholecystostomy in Grade III or surgical high-risk patients

---

3. CHOLEDOCHOLITHIASIS

Pathophysiology

Classic Presentation (Triad)

Choledocholithiasis Triad:

1. RUQ/epigastric pain
2. Jaundice (obstructive — dark urine, pale stools)
3. Elevated liver enzymes — conjugated hyperbilirubinaemia, ↑ALP, ↑GGT

Signs

• Jaundice (scleral icterus)
• Dark urine, pale/acholic stools, pruritus
• No fever unless secondary cholangitis develops
• Courvoisier's Sign absent (gallbladder usually fibrosed from chronic stone disease → NOT distended)

Investigations

• US: CBD dilation (>6–7 mm; >10 mm post-cholecystectomy), possible CBD stone visualisation (~50% sensitivity)
• MRCP: non-invasive, gold standard for diagnosis (~95% sensitivity)
• ERCP: diagnostic AND therapeutic
• Labs: ↑bilirubin (conjugated), ↑ALP, ↑GGT; aminotransferases mildly elevated; ↑lipase if pancreatitis

Management

• ERCP with sphincterotomy + stone extraction — first-line
• Laparoscopic CBD exploration (at time of cholecystectomy)
• Percutaneous transhepatic cholangiography (PTC) if ERCP fails or anatomy altered
• Cholecystectomy after CBD clearance

---

4. ACUTE CHOLANGITIS

Pathophysiology

⭐ Charcot's Triad (1877)

1. Fever with chills/rigors (~95% of patients, usually >38.5°C)
2. Jaundice (conjugated hyperbilirubinaemia)
3. RUQ pain

Specificity: high (~95%) | Sensitivity: low (~26%)

⭐⭐ Reynolds' Pentad (Severe/Suppurative Cholangitis)

Charcot's Triad PLUS: 4. Hypotension (septic shock) 5. Altered mental status / confusion

Seen in <10% of cholangitis cases; mortality approaches 100% without urgent drainage

Signs

• Jaundice (universal in full Charcot's triad)
• RUQ tenderness
• Tachycardia, tachypnoea, hypotension (in severe cases)
• Altered sensorium (Reynolds' pentad)
• US: dilated CBD (>7 mm), intrahepatic duct dilation

Investigations

• Labs: leukocytosis, ↑bilirubin, ↑ALP, ↑GGT, moderately ↑transaminases, blood cultures positive in ~50%
• US: CBD dilation; stones if present
• ERCP: diagnostic and therapeutic gold standard
• CT/MRCP: if US inconclusive

Management (Tokyo Guidelines)

• Immediate: IV fluids, blood cultures, broad-spectrum antibiotics
  • Ampicillin-sulbactam 3 g IV q6h OR Piperacillin-tazobactam 3.375 g IV q6h
  • Add metronidazole for anaerobic coverage in severe cases
• Biliary decompression (<24 h in severe cholangitis / Reynolds' pentad):
  • ERCP + sphincterotomy (first-line) — stone extraction, stent placement
  • Percutaneous transhepatic biliary drainage (PTBD) if ERCP fails
  • Surgical drainage (last resort)
• ICU admission for Reynolds' pentad
• Antibiotics continued 4–7 days after source control

---

5. MIRIZZI SYNDROME

Pathophysiology

Types

Classic Presentation (Triad)

1. Obstructive jaundice (painful, unlike malignant)
2. Recurrent cholangitis (fever, RUQ pain)
3. History of chronic cholelithiasis

Signs

• Jaundice
• RUQ tenderness
• Important: Courvoisier's sign usually ABSENT (gallbladder contracted)
• May mimic cholangiocarcinoma on imaging

Investigations

• MRCP/ERCP: establishes diagnosis, shows CHD compression by external stone
• US/CT: may miss — MRCP/ERCP superior
• Intraoperative: most commonly diagnosed during difficult cholecystectomy

Management

• Type I: Cholecystectomy ± CBD exploration
• Type II: Cholecystectomy + reconstruction (biliary-enteric anastomosis, e.g., Roux-en-Y hepaticojejunostomy)
• Laparoscopic approach possible in experienced hands; open surgery often required for Type II

---

6. PRIMARY SCLEROSING CHOLANGITIS (PSC)

Pathophysiology

Classic Presentation (Triad)

1. Pruritus (bile salt deposition)
2. Fatigue
3. Progressive cholestatic jaundice

Many patients are asymptomatic at diagnosis (found on abnormal LFTs)

Signs

• Jaundice (late)
• Xanthelasma, xanthomas (chronic cholestasis)
• Signs of portal hypertension and cirrhosis (spider naevi, ascites, splenomegaly) — late
• Features of IBD (ulcerative colitis in majority)
• ↑ risk of cholangiocarcinoma (~10–15% lifetime risk)

Investigations

• MRCP: "beads-on-a-string" pattern — alternating strictures and dilations of bile ducts (gold standard)
• ERCP: diagnostic and therapeutic (balloon dilation, stenting of dominant strictures)
• Liver biopsy: "onion-skin" periductal fibrosis (pathognomonic)
• Labs: ↑ALP, ↑GGT, mildly ↑bilirubin; p-ANCA positive in ~80%; normal or near-normal transaminases
• Colonoscopy to screen for/assess IBD

Management

• No proven medical therapy to halt progression
• Ursodeoxycholic acid (UDCA): controversial — may improve LFTs but not shown to reduce mortality or prevent cholangiocarcinoma
• Endoscopic therapy (ERCP): balloon dilation ± short-term stenting of dominant strictures
• Cholestyramine for pruritus; rifampicin as second line
• Liver transplantation — only curative treatment; indication: end-stage liver disease, recurrent cholangitis, intractable pruritus
• Annual MRCP ± CA 19-9 surveillance for cholangiocarcinoma

---

7. PRIMARY BILIARY CHOLANGITIS (PBC) — formerly Primary Biliary Cirrhosis

Pathophysiology

Classic Presentation (Triad)

1. Pruritus (often the presenting complaint — may precede jaundice by years)
2. Fatigue
3. Cholestatic jaundice + xanthelasma (late)

Signs

• Kayser-Fleischer rings absent (unlike Wilson's disease)
• Xanthelasma, xanthomas
• Hepatosplenomegaly
• Signs of portal hypertension and cirrhosis (late)
• Associated autoimmune conditions: Sjögren's syndrome, CREST, autoimmune thyroiditis, RA

Investigations

• Anti-mitochondrial antibodies (AMA) M2 — positive in >95%; highly specific
• ↑ALP, ↑GGT, mildly ↑bilirubin (late); ↑IgM
• Liver biopsy: florid duct lesion — granulomatous destruction of bile ducts (diagnostic stages I–IV)
• MRCP: normal or mild intrahepatic changes (excludes PSC)

Management

• Ursodeoxycholic acid (UDCA) 13–15 mg/kg/day — first-line; slows progression, improves LFTs and transplant-free survival
• Obeticholic acid — second-line for UDCA non-responders (FXR agonist)
• Pruritus: cholestyramine → rifampicin → naltrexone → sertraline
• Fatigue: no specific therapy
• Osteoporosis prevention: calcium + vitamin D supplementation
• Fat-soluble vitamin supplementation (A, D, E, K) in advanced disease
• Liver transplantation: end-stage disease; excellent post-transplant outcomes

---

8. CHOLANGIOCARCINOMA (Bile Duct Cancer)

Types

Classic Presentation

Cholangiocarcinoma Triad (Hilar/Distal):

1. Progressive painless jaundice (obstructive)
2. Pruritus
3. Weight loss / cachexia

⭐ Courvoisier's Law / Sign

Painless jaundice + palpable, non-tender gallbladder = malignant CBD obstruction until proven otherwise

Rationale: In gallstone disease, the GB is fibrosed and scarred (cannot distend). In malignant obstruction (cholangiocarcinoma, pancreatic head cancer, ampullary cancer), the GB is normal and distends proximal to the obstruction.

Note: Courvoisier's sign is present in only ~25–50% of malignant obstructions — absence does NOT exclude malignancy.

Signs

• Jaundice with scratch marks (pruritus)
• Hepatomegaly
• Palpable gallbladder (Courvoisier's sign) — distal tumours
• Cachexia
• Trousseau sign (migratory thrombophlebitis) — paraneoplastic
• Virchow's node (left supraclavicular node) — advanced disease

Investigations

• MRCP: ductal anatomy, level of obstruction
• CT abdomen with contrast: staging, vascular involvement
• ERCP: diagnostic biopsies via brush cytology, biliary decompression (stenting)
• CA 19-9 and CEA: elevated, limited sensitivity/specificity; useful for monitoring
• PET scan: distant metastasis
• Bismuth-Corlette classification for hilar CCA (Types I–IV)

Management

• Surgical resection: only curative option
  • Hilar: major hepatectomy + bile duct resection ± caudate lobe resection
  • Distal: Whipple procedure (pancreaticoduodenectomy)
  • Intrahepatic: hepatic resection
• Liver transplantation: selected Klatskin tumours (<3 cm, no nodal/vascular spread) — Mayo protocol with neoadjuvant chemoradiation
• Palliative stenting (ERCP or PTBD): for unresectable disease — biliary decompression
• Chemotherapy: gemcitabine + cisplatin ± durvalumab (standard for unresectable/metastatic)
• Photodynamic therapy (PDT) / ablative therapies: selected cases

---

9. GALLSTONE PANCREATITIS

Pathophysiology

Classic Presentation (Triad — Ranson/Clinical)

1. Epigastric pain radiating to the back
2. Nausea/vomiting
3. ↑ Serum lipase/amylase (lipase >3× ULN diagnostic)

Jaundice may be present if stone persists in CBD

Signs

• Cullen's sign: periumbilical ecchymosis (haemorrhagic pancreatitis)
• Grey Turner's sign: flank ecchymosis (retroperitoneal haemorrhage)
• Fox's sign: inguinal ligament ecchymosis
• Epigastric tenderness ± guarding
• Absent bowel sounds (ileus)

Investigations

• Lipase (preferred) and amylase — >3× ULN
• US: gallstones, CBD dilation, pancreatic oedema
• CT with contrast (at 48–72 h): Balthazar/CTSI scoring for severity, necrosis detection
• MRCP: if CBD stones suspected without dilated duct on US
• LFTs: ↑ALT >3× ULN suggests gallstone aetiology

Management

• IV fluids (aggressive early resuscitation — lactated Ringer's preferred)
• Analgesia (opioids), NPO vs. early enteral feeding (nasojejunal preferred in severe cases)
• ERCP within 24–72 h if concomitant cholangitis or persistent CBD obstruction
• Antibiotics only for infected necrotising pancreatitis (not prophylactic)
• Cholecystectomy during same admission (mild pancreatitis) or after recovery (severe) — prevents recurrence

---

10. ACALCULOUS CHOLECYSTITIS

Pathophysiology

Classic Presentation (Triad)

1. RUQ pain or unexplained fever in critically ill patient
2. Leukocytosis
3. Elevated liver enzymes / bilirubin

Often masked by sedation/analgesia in ICU — high index of suspicion required

Signs

• Murphy's sign may be absent (sedated patients)
• Sepsis without obvious source in ICU patient

Management

• Percutaneous cholecystostomy — preferred in unstable patients (bedside US-guided)
• Antibiotics: as for calculous cholecystitis
• Laparoscopic/open cholecystectomy once patient stabilised

---

11. GALLBLADDER CARCINOMA

Classic Presentation (Triad)

1. RUQ pain (most common — ~75%)
2. Jaundice (CBD involvement)
3. Weight loss / anorexia

Signs

• Palpable RUQ mass (late)
• Jaundice + Courvoisier's sign (if CBD infiltrated)
• Signs of metastasis (ascites, hepatomegaly)

Management

• T1a: simple cholecystectomy (curative)
• T1b–T2: extended cholecystectomy (en bloc liver segments IVb + V + portal lymphadenectomy)
• T3–T4: resection if feasible; often palliative stenting + gemcitabine/cisplatin
• Incidental finding post-cholecystectomy: re-resection based on depth of invasion

---

12. BILIARY STRICTURES

Causes

Classic Presentation

1. Obstructive jaundice
2. Pruritus
3. Recurrent cholangitis (if incomplete)

Management

• Benign: ERCP with balloon dilation ± stenting; surgical biliary-enteric anastomosis (Roux-en-Y hepaticojejunostomy) for failed endoscopic therapy
• Malignant: as per cholangiocarcinoma management above

---

SUMMARY TABLE: Triads & Pentads of Biliary Tract Disease

---

ANTIBIOTIC REFERENCE FOR BILIARY INFECTIONS

---

---

Management of Conjunctivitis

With Generic & Brand Names Available in Pakistan

---

Classification & Approach

---

1. BACTERIAL CONJUNCTIVITIS

Common organisms

General Principle

---

A. FLUOROQUINOLONES (First-line - broad spectrum)

Moxifloxacin 0.5% Eye Drops

• Mechanism: 4th-generation fluoroquinolone; inhibits DNA gyrase + topoisomerase IV; bactericidal; excellent gram-positive AND gram-negative coverage
• Dose: 1 drop 3 times/day for 7 days
• Advantage: Preservative-free, no risk of corneal toxicity; best coverage including MRSA strains

---

Ciprofloxacin 0.3% Eye Drops / Ointment

• Mechanism: 2nd-generation fluoroquinolone; inhibits DNA gyrase; good gram-negative coverage especially P. aeruginosa
• Dose (drops): 1–2 drops every 2 hours while awake for 2 days, then every 4 hours for 5 more days
• Dose (ointment): ½ inch ribbon 3× daily × 7 days
• Note: White crystalline precipitates may form on cornea (harmless but alarming)

---

Ofloxacin 0.3% Eye Drops

• Mechanism: 2nd-generation fluoroquinolone; broad spectrum; good corneal penetration
• Dose: 1–2 drops every 2–4 hours × 2 days, then QID × 5 days

---

B. CHLORAMPHENICOL 0.5% Eye Drops / 1% Ointment

• Mechanism: Bacteriostatic; broad spectrum (gram +ve and –ve); inhibits 50S ribosomal subunit
• Dose (drops): 1–2 drops every 3 hours; continue 48 hours after eye appears normal
• Dose (ointment): Small amount every 3 hours, especially at night
• Warning: Rare risk of aplastic anaemia (systemic absorption from topical use) — not recommended in children under 2 years; avoid in pregnancy
• Still very commonly used in Pakistan due to availability and low cost

---

C. TOBRAMYCIN 0.3% Eye Drops / Ointment

• Mechanism: Aminoglycoside; bactericidal; inhibits 30S + 50S ribosomal subunits; excellent gram-negative (especially P. aeruginosa) coverage
• Dose: 1–2 drops every 4 hours (severe: every hour for 24–48 h, then reduce)
• Use: Contact lens-associated conjunctivitis, suspected Pseudomonas

---

D. GENTAMICIN 0.3% Eye Drops

• Mechanism: Aminoglycoside; bactericidal; gram-negative coverage
• Dose: 1–2 drops every 4 hours

---

E. SULPHACETAMIDE 10–20% Eye Drops

• Mechanism: Sulphonamide; bacteriostatic; inhibits folate synthesis
• Dose: 1–2 drops every 2–3 hours, tapering as infection improves
• Still widely used in Pakistan as affordable first-line option

---

2. VIRAL CONJUNCTIVITIS

Most Cases (Adenoviral)

• Treatment: SUPPORTIVE ONLY
• Cool compresses, lubricating eye drops (artificial tears)
• Avoid topical steroids (can prolong infection and cause corneal scarring)
• Avoid antibiotics (no bacterial infection present — antibiotic misuse is widespread)
• Highly contagious — strict hand hygiene, avoid sharing towels/pillows

---

Herpes Simplex Virus (HSV) Conjunctivitis / Keratoconjunctivitis

Acyclovir 3% Eye Ointment

• Mechanism: Nucleoside analogue; inhibits viral DNA polymerase
• Dose: 1 cm ribbon instilled 5× daily (every 4 hours while awake) × 7–10 days
• Always refer to ophthalmologist — dendritic corneal ulcer is an emergency

---

Herpes Zoster Ophthalmicus (VZV affecting eye)

• Oral acyclovir 800 mg 5× daily × 7–10 days or valacyclovir 1 g TDS × 7 days
• Topical acyclovir ointment as adjunct
• Urgent ophthalmology referral

---

3. ALLERGIC CONJUNCTIVITIS

---

STEP 1: Non-pharmacological

• Remove allergen
• Cool compresses
• Avoid rubbing eyes (mast cell degranulation is worsened by rubbing)
• Wear wraparound glasses outdoors

---

STEP 2: Antihistamine Eye Drops

Olopatadine (Antihistamine + Mast Cell Stabiliser — DUAL action, PREFERRED)

• Mechanism: H1 receptor antagonist + mast cell stabiliser; inhibits histamine release AND blocks its effects
• 0.1% dose: 1 drop twice daily
• 0.2% dose: 1 drop once daily (for perennial/seasonal)

---

Ketotifen 0.025% Eye Drops (Antihistamine + Mast Cell Stabiliser)

• Dose: 1 drop twice daily

---

Levocabastine 0.05% Eye Drops (Antihistamine)

• Dose: 1 drop 2–4× daily

---

STEP 3: Mast Cell Stabilisers (Preventive - for seasonal use)

Sodium Cromoglycate 2–4% Eye Drops

• Mechanism: Prevents mast cell degranulation; start 2 weeks before allergy season
• Dose: 1–2 drops 4× daily

---

STEP 4: NSAID Eye Drops (For itching/inflammation without steroids)

Ketorolac 0.5% Eye Drops

• Dose: 1 drop 4× daily

Nepafenac 0.1–0.3%

---

STEP 5: Topical Steroids (for SEVERE allergic conjunctivitis / VKC only)

Prednisolone Acetate 1%

Fluorometholone 0.1% (Safer steroid — less IOP-raising)

Loteprednol Etabonate 0.5% (Safest steroid for eye — metabolised locally)

---

STEP 6: Oral Antihistamines (adjunct for systemic allergic symptoms)

---

4. CHLAMYDIAL CONJUNCTIVITIS (Inclusion Conjunctivitis)

Treatment

• Azithromycin 1 g oral single dose (drug of choice) OR
• Doxycycline 100 mg BD × 7 days (adults)
• Plus topical: Azithromycin 1% eye drops × 3 days (AzaSite) OR Erythromycin ointment × 2–3 weeks

---

5. GONOCOCCAL CONJUNCTIVITIS (Hyperacute — EMERGENCY)

• Systemic: Ceftriaxone 1 g IM single dose (adults); 25–50 mg/kg IM for neonates
• Topical: Ciprofloxacin or bacitracin drops hourly
• Lavage: Saline irrigation of eye every hour
• Immediate ophthalmology referral — risk of corneal perforation within 24–48 hours

---

6. NEONATAL CONJUNCTIVITIS (Ophthalmia Neonatorum)

---

COMBINATION ANTIBIOTIC + STEROID DROPS

---

SUMMARY ALGORITHM

CONJUNCTIVITIS
│
├─ ITCHING (hallmark)?
│   → ALLERGIC → Olopatadine (Zolopat/Patanol) ± oral antihistamine
│                 Severe → Add topical steroid (FML/Pred Forte) under ophthalmologist
│
├─ WATERY discharge + preauricular node + no itch?
│   → VIRAL → Supportive: artificial tears + cool compresses
│              HSV suspected? → Acyclovir ointment (Lovir) + URGENT referral
│
├─ PURULENT/MUCOPURULENT discharge + morning crusting?
│   → BACTERIAL → Moxifloxacin (Vigamox/Ocumox) 3× daily × 7 days
│                  OR Chloramphenicol (Chloroptic) every 3 hrs
│                  OR Ciprofloxacin (Ciloxan) if Pseudomonas risk
│
├─ CHRONIC follicular + sexually active/neonate?
│   → CHLAMYDIAL → Azithromycin 1 g stat PO + topical tetracycline
│
└─ HYPERACUTE copious pus within hours?
    → GONOCOCCAL → Ceftriaxone IM + EMERGENCY referral

---

KEY SAFETY REMINDERS

1. Never prescribe topical steroids without slit-lamp examination — steroids + HSV dendritic ulcer = corneal perforation
2. Chloramphenicol — avoid in neonates and pregnancy (rare aplastic anaemia)
3. Fluoroquinolones — preferred over aminoglycosides for corneal penetration
4. Contact lens wearers — always use preservative-free drops and treat for Pseudomonas (tobramycin or ciprofloxacin)
5. Viral conjunctivitis — antibiotics are not indicated and contribute to antimicrobial resistance

---

---

Atypical Presentations: When One Condition Masks or Distorts Another

---

CATEGORY 1: NEUROPATHY MASKING PAIN SIGNALS

---

1.1 Diabetic Neuropathy + Myocardial Infarction

• Normal presentation: Crushing central chest pain radiating to jaw/left arm
• Atypical: Abdominal pain, nausea, fatigue, vomiting, or completely silent MI — patient presents with heart failure or arrhythmia as the first sign
• Mechanism: Autonomic and somatic neuropathy disrupts cardiac afferent fibres (C fibres via T1–T5 sympathetics)
• Magnitude: Silent MI accounts for up to 25% of all MIs in diabetics; up to 40% of diabetics with coronary artery disease have no anginal symptoms

---

1.2 Diabetic Neuropathy + Acute Abdomen

• Normal presentation: Peritonitis → board-like rigidity, guarding, rebound tenderness
• Atypical: Reduced or absent abdominal tenderness in diabetic with perforated viscus, mesenteric ischaemia, or gangrenous appendix
• Mechanism: Visceral and somatic pain fibres are both damaged
• Trap: Normal physical exam does NOT exclude surgical emergency in a diabetic with peripheral + autonomic neuropathy

---

1.3 Diabetic Neuropathy + Charcot Foot Osteomyelitis

• Normal presentation: Bone infection → severe pain, fever, point tenderness
• Atypical: Warm, swollen, red foot with no pain — patient continues walking, fractures are missed for weeks
• Mechanism: Peripheral neuropathy removes protective pain sensation
• Result: Often misdiagnosed as cellulitis, gout, or DVT

---

1.4 Diabetic Neuropathy + Urinary Tract Infection / Pyelonephritis

• Normal: Flank pain, dysuria, frequency
• Atypical: Asymptomatic bacteriuria, or presents with sepsis with no urinary symptoms; emphysematous pyelonephritis found incidentally on CT
• Mechanism: Autonomic neuropathy of bladder + reduced visceral pain sensation

---

1.5 Spinal Cord Injury + Appendicitis / Cholecystitis / Any Acute Abdomen

• Normal: Pain localised to affected quadrant
• Atypical: No pain below the level of injury. Patient may only have autonomic dysreflexia (bradycardia, hypertension, flushing, sweating above level of lesion) as the "alarm signal"
• Mechanism: Afferent pain pathways from abdomen travel below the cord lesion level

---

1.6 Leprosy (Peripheral Neuropathy) + Injury / Septic Arthritis

• Normal: Pain with injury, joint infection
• Atypical: Traumatic injuries, burns, joint destruction (Charcot joints) with no pain — patient presents with deformity or sepsis
• Mechanism: Peripheral nerve damage (M. leprae tropism for myelin)

---

1.7 Tabes Dorsalis (Tertiary Syphilis) + Visceral Pain

• Normal: Abdominal pain with visceral disease
• Atypical: "Tabetic crises" — paroxysmal severe pain in absence of any pathology, OR complete absence of pain with genuine abdominal disease
• Mechanism: Posterior column and dorsal root ganglion destruction

---

CATEGORY 2: DRUGS MASKING SYMPTOMS

---

2.1 Beta-Blockers + Hypoglycaemia

• Normal hypoglycaemia signs: Tachycardia, tremor, anxiety, palpitations (adrenergic symptoms), pallor
• Atypical: All adrenergic warning signs are blocked; sweating may persist (cholinergic, not blocked by beta-blockers)
• Mechanism: β1/β2 blockade inhibits epinephrine-driven tachycardia and tremor
• Danger: Patient loses the early warning and presents with seizure or coma
• Note: Beta-blockers also prolong the hypoglycaemic episode by inhibiting glycogenolysis

---

2.2 Beta-Blockers + Thyrotoxicosis

• Normal: Tachycardia, tremor, heat intolerance, agitation
• Atypical: All these are controlled; thyrotoxicosis may go undiagnosed for months while beta-blocker "treats" the symptoms
• Mechanism: Beta-blockade suppresses adrenergic manifestations of excess thyroid hormone

---

2.3 Beta-Blockers + Anaphylaxis

• Normal: Epinephrine → bronchodilation, vasoconstriction, reversal of anaphylaxis
• Atypical: Beta-blockade makes anaphylaxis refractory to epinephrine; presents as prolonged, severe, treatment-resistant anaphylaxis
• Mechanism: β2 receptors mediate bronchodilation; blocked → bronchospasm persists; also prevents counter-regulatory vasoconstriction

---

2.4 NSAIDs / Analgesics + Peritonitis / Appendicitis

• Normal: Worsening abdominal pain over time
• Atypical: Pain relief from analgesic delays diagnosis; signs of peritonism are diminished on examination
• Classic teaching (now contested): Previously, analgesics were withheld in acute abdomen for this reason; modern evidence shows withholding analgesia is unethical and does not impair diagnosis significantly — but recognition matters

---

2.5 Corticosteroids + Serious Infections (Bacterial, Fungal, TB)

• Normal: Fever, elevated CRP/WBC, signs of inflammation (rubor, calor, dolor, tumor)
• Atypical: All suppressed by steroids. Patient on long-term steroids may have peritonitis without fever, pneumonia without cough/fever, meningitis without neck stiffness, septic arthritis without joint inflammation
• Mechanism: Steroids suppress cytokine cascade, neutrophil migration, and the entire inflammatory response
• Additional: Steroids mask the lymphocytopenia expected in TB, may suppress ESR/CRP in active lupus flare

---

2.6 Corticosteroids + Bowel Perforation in IBD / Transplant Patients

• Normal: Perforation → peritonitis, rigidity, acute abdomen
• Atypical: Minimal or no peritoneal signs; patient may look "not that sick" while having free air on CT
• Mechanism: Anti-inflammatory effect abolishes peritoneal response

---

2.7 Opioids + Acute Abdomen

• Normal: Progressive pain worsening
• Atypical: Masked pain; patient on chronic opioids for pain has baseline high pain tolerance; bowel obstruction, perforation may be missed
• Additional: Opioid-induced constipation mimics bowel obstruction

---

2.8 Antibiotics (Partial Treatment) + Meningitis / Bacterial Endocarditis

• Normal: Classic triad of meningitis (fever, neck stiffness, photophobia) or Osler nodes / Janeway lesions in endocarditis
• Atypical: Partial antibiotic treatment blunts the CSF pleocytosis (making LP less diagnostic), reduces fever, normalises CRP — but does NOT eradicate the infection
• Mechanism: Antibiotics reduce bacterial load and cytokine release enough to suppress signs but not cure

---

2.9 Diuretics + Hyperaldosteronism / Hypokalaemia

• Normal hyperaldosteronism signs: Hypertension, hypokalaemia, muscle weakness
• Atypical: Diuretics cause independent hypokalaemia and hypertension → masks the underlying primary hyperaldosteronism (Conn's syndrome) making biochemical diagnosis unreliable
• Mechanism: Both diuretics and aldosterone excess lower serum K+

---

CATEGORY 3: AGE-RELATED BLUNTING OF RESPONSES

---

3.1 Elderly + Pneumonia

• Normal: Fever, productive cough, pleuritic chest pain, raised WBC
• Atypical: Confusion (delirium), falls, "off legs", anorexia, tachycardia without fever, normal or even LOW WBC (leukopenia)
• Mechanism: Immunosenescence blunts cytokine response; blunted thermoregulation; delirium is the elderly brain's non-specific response to illness

---

3.2 Elderly + Myocardial Infarction

• Normal: Chest pain
• Atypical: Fatigue, confusion, syncope, epigastric pain, vomiting — chest pain is absent in up to 40% of elderly MI patients
• Mechanism: Reduced pain perception with aging; multiple comorbidities alter the clinical picture

---

3.3 Elderly + Urinary Tract Infection / Sepsis

• Normal: Dysuria, frequency, fever, flank pain
• Atypical: Confusion, falls, functional decline, urinary incontinence — no urinary symptoms at all
• Mechanism: Attenuated febrile and inflammatory response; baseline lower cognitive reserve reveals earlier as delirium

---

3.4 Elderly + Appendicitis

• Normal: Migratory pain RIF, fever, raised WBC, peritonism
• Atypical: Vague abdominal discomfort, minimal fever, normal WBC — patient presents late with perforated appendix
• Mechanism: Blunted inflammatory response + thicker omentum may wall off the infection silently

---

3.5 Elderly + Hyperthyroidism ("Apathetic Thyrotoxicosis")

• Normal: Agitation, tremor, heat intolerance, weight loss, tachycardia
• Atypical: Apathy, lethargy, depression, weight loss only — the classic hyperadrenergic features are absent
• Mechanism: Reduced adrenergic receptor sensitivity with aging; β-receptor downregulation

---

3.6 Elderly + Acute Abdomen / Bowel Obstruction

• Normal: Severe pain, vomiting, distension
• Atypical: Minimal pain, vague discomfort; first presentation may be septic shock from strangulated bowel
• Mechanism: Blunted visceral pain perception; multiple prior surgeries may alter anatomy

---

CATEGORY 4: ANATOMICAL DISPLACEMENT / STRUCTURAL ANOMALY

---

4.1 Pregnancy + Appendicitis

• Normal: Pain at McBurney's point (RIF)
• Atypical: As the uterus enlarges, the appendix is displaced upward and laterally — pain may be in RUQ, right flank, or right upper quadrant in the 2nd/3rd trimester
• Mechanism: Gravid uterus physically displaces the appendix (though MRI studies show less displacement than classically taught, it is still significantly altered)
• Additional trap: Nausea/vomiting of pregnancy masks early symptoms; elevated WBC is normal in pregnancy

---

4.2 Situs Inversus + Any Right-Sided Pathology

• Normal appendicitis: Right iliac fossa pain
• Atypical: Left iliac fossa pain (appendix is on left side)
• Normal MI: Left-sided chest pain
• Atypical: Right-sided chest pain
• Mechanism: Complete mirror-image organ reversal

---

4.3 Horseshoe Kidney / Pelvic Kidney + Renal Colic

• Normal renal colic: Flank pain radiating to groin
• Atypical: Central abdominal pain, pelvic pain — completely different radiation pattern based on nerve supply of ectopic position
• Mechanism: Ectopic kidney innervation via lumbar/sacral plexus rather than T10–L1

---

4.4 Malrotation + Midgut Volvulus (Adult)

• Normal bowel obstruction: Central colicky pain, vomiting, distension
• Atypical: Vague chronic intermittent pain, diagnosed as IBS for years; acute presentation can be catastrophic
• Mechanism: Incomplete intestinal rotation leaves small bowel on a narrow vascular pedicle that intermittently twists

---

4.5 Retrocaecal Appendix + Appendicitis

• Normal: RIF pain, psoas sign positive
• Atypical: Posterior/flank pain (may mimic renal colic), minimal anterior guarding, positive Obturator or psoas sign only
• Mechanism: Posterior location means anterior peritoneum is not irritated

---

4.6 Subphrenic Abscess / Diaphragmatic Irritation

• Normal: Localised abdominal pain near abscess
• Atypical: Right shoulder tip pain (referred via phrenic nerve, C3–C5)
• Mechanism: Diaphragmatic peritoneal irritation → referred pain to shoulder via phrenic nerve

---

CATEGORY 5: IMMUNOSUPPRESSION MASKING INFECTION / INFLAMMATION

---

5.1 HIV/AIDS + Tuberculosis (Atypical TB)

• Normal TB: Upper lobe cavitary lesion, cough, night sweats, haemoptysis
• Atypical: Lower lobe or diffuse infiltrates, miliary pattern, extrapulmonary TB (meningitis, peritonitis, pericarditis) — the classic presentation requires intact CD4 immunity to form cavities
• Mechanism: Cavitation requires macrophage-driven granuloma formation (Th1 response) → absent in advanced HIV
• CD4 guide: CD4 >200: relatively typical; CD4 <200: increasing atypicality; CD4 <50: miliary/disseminated

---

5.2 HIV/AIDS + Pneumocystis Pneumonia (PCP) vs Typical Pneumonia

• Normal bacterial pneumonia: Acute fever, productive cough, lobar consolidation on CXR
• Atypical PCP: Insidious onset, dry cough, exertional dyspnoea, bilateral perihilar/interstitial infiltrates or even normal CXR — LDH elevated
• Mechanism: Different pathogen requiring different immunity; PCP triggers an atypical interstitial pattern

---

5.3 HIV/AIDS + Syphilis ("Malignant Syphilis")

• Normal secondary syphilis: Maculopapular rash including palms/soles, mild illness
• Atypical: Rupial (crusted, oyster-shell) ulcerations, fulminant multiorgan involvement, rapid progression to tertiary
• Mechanism: CD4+ T-cell mediated immune control is lost

---

5.4 Transplant Patient / High-Dose Steroids + CMV Disease

• Normal CMV in immunocompetent: Self-limited mononucleosis-like illness
• Atypical in immunosuppressed: CMV pneumonitis, CMV colitis (diarrhoea/haematochezia), CMV retinitis, CMV encephalitis — any organ can be targeted
• Mechanism: CMV is latent; reactivates when T-cell surveillance is lost

---

5.5 Neutropenic Patient (Chemotherapy) + Bacterial Infection

• Normal infection: Redness, pus, swelling, fever
• Atypical: No pus (no neutrophils to generate it), minimal erythema, fever may be the ONLY sign
• Classic trap: Neutropenic patient with perianal pain and erythema — this is a life-threatening necrotising infection but looks deceptively mild
• Rule: Fever in a neutropenic patient = emergency, regardless of other signs

---

5.6 Diabetic Patient + Fungal Infection (Mucormycosis, Candida)

• Normal: Obvious inflammatory signs
• Atypical in uncontrolled DM: Rhinocerebral mucormycosis may initially present as orbital cellulitis, toothache, or nasal congestion before rapidly invading the skull base
• Mechanism: Hyperglycaemia impairs neutrophil function + high glucose/ketones support fungal growth

---

CATEGORY 6: ONE DISEASE MIMICS ANOTHER DIRECTLY

---

6.1 Phaeochromocytoma + "Panic Attack" / "Essential Hypertension"

• Misdiagnosis: Palpitations, sweating, anxiety, headache — treated as panic disorder for years
• Actual: Catecholamine crisis from adrenal tumour
• Concurrent condition making it worse: If on tricyclic antidepressants (for the "panic attacks") → TCA blocks noradrenaline reuptake → hypertensive crisis

---

6.2 Addison's Disease (Adrenal Insufficiency) + Acute Abdomen

• Atypical: Severe nausea, vomiting, abdominal pain, hypotension — mimics acute surgical abdomen
• Trap: Patient taken to theatre; adrenal crisis worsens with surgical stress
• Concurrent masking: If patient is also taking long-term steroids for another condition, the endogenous adrenal suppression is hidden until steroid is suddenly stopped or infection hits

---

6.3 Hypercalcaemia (Any Cause) + "Psychiatric" / "GI" Disease

• Symptoms: Confusion, depression, constipation, nausea, polyuria, weakness
• Trap: Each symptom is treated separately — depression with SSRIs, constipation with laxatives, confusion written off as dementia
• Concurrent masking: If also on thiazide diuretics (used for hypertension common in same demographic) → thiazides increase renal calcium reabsorption → worsens hypercalcaemia

---

6.4 Hypothyroidism + Depression / Dementia

• Atypical: Slow thinking, low mood, weight gain, constipation — ALL treated as primary psychiatric or geriatric disease
• Concurrent masking: Elderly patients with multiple medications may have TSH suppressed by dopamine, amiodarone, or steroids — falsely "normalising" thyroid tests
• Amiodarone: Can cause either hypothyroidism OR thyrotoxicosis; masks both by affecting thyroid hormone conversion (T4→T3)

---

6.5 Pulmonary Embolism + Heart Failure / COPD

• Normal PE: Acute dyspnoea, pleuritic chest pain, haemoptysis
• Atypical: In a patient with known heart failure or COPD, acute deterioration is attributed to the known disease
• Mechanism: Background chronic hypoxia and dyspnoea mask the acuity of new PE; D-dimer is chronically elevated in these patients → loses diagnostic value
• Concurrent trap: Anticoagulants given for AF may reduce (but not eliminate) PE risk — clinician assumes PE is "covered"

---

6.6 Diabetic Ketoacidosis (DKA) Masking Intra-abdominal Pathology

• Normal DKA: Abdominal pain in up to 80% of cases — usually resolves with DKA treatment
• Trap: If abdominal pain DOES NOT resolve after DKA correction → must actively rule out the precipitant (appendicitis, cholecystitis, mesenteric ischaemia)
• Mechanism: DKA itself causes ileus, gaseous distension, and gastric stasis → produces genuine abdominal pain independent of any surgical cause

---

6.7 Hypothyroidism + Hyponatraemia Masking SIADH

• Normal SIADH: Diagnosed by clinical + biochemical criteria
• Atypical: Hypothyroidism itself causes hyponatraemia by reducing free water clearance and cardiac output
• Trap: If hyponatraemia is "treated" without finding hypothyroidism → water restriction makes patient worse and does not address the cause
• Concurrent: If patient also has heart failure (causing dilutional hyponatraemia) — three simultaneous causes of low sodium

---

6.8 Cardiac Tamponade + "Sepsis" / "Tension Pneumothorax"

• Normal tamponade: Beck's triad (hypotension, raised JVP, muffled heart sounds)
• Atypical: In sepsis, JVP may be low (masking the raised JVP); if patient is intubated and ventilated, muffled sounds are missed; tachycardia and hypotension attributed to sepsis
• Concurrent: Post-cardiac surgery patient on vasopressors — tamponade masked by pharmacological blood pressure support

---

CATEGORY 7: PSYCHIATRIC / COGNITIVE CONDITIONS ALTERING SYMPTOM REPORTING

---

7.1 Dementia + Any Acute Illness

• Normal: Patient describes symptoms → history-guided diagnosis
• Atypical: Patient cannot localise or communicate pain → only behavioural change (agitation, withdrawal, refusal to eat) signals illness
• Masking: Dementia makes ALL acute illnesses atypical by default — UTI, MI, hip fracture, mesenteric ischaemia all present as "acute confusion"

---

7.2 Schizophrenia / Psychosis + Acute Illness

• Normal: Patient reports pain and distress
• Atypical: Patients with schizophrenia have reduced pain perception (blunted interoception) AND their pain complaints may be dismissed as delusional
• Documented cases: Schizophrenic patients have presented with perforated bowel, fractures, and massive MI with no complaint
• Double trap: Antipsychotics (especially clozapine) cause agranulocytosis → masks infection signs; also cause paralytic ileus

---

7.3 Autism Spectrum Disorder + Pain

• Atypical: Altered pain processing; may not communicate pain or may express it atypically; self-injurious behaviour may be the pain signal
• Clinical impact: Appendicitis, ear infections, dental pain all routinely missed

---

7.4 Somatisation Disorder / Functional Neurological Symptoms + Real Organic Disease

• Trap: Patient labelled as "anxious" or "somatic" based on previous history → new symptoms dismissed as psychological
• Classic case: Patient with known fibromyalgia develops real cord compression → dismissed as "usual pain" until paralysis
• The "cry wolf" effect: Frequent attenders have real emergencies missed

---

SUMMARY MASTER TABLE

---

THE CLINICAL PRINCIPLE

The more comorbidities a patient has, the less reliable the classic presentation of any new disease. The diseases do not simply add up — they interact, mask, mimic, and amplify each other in unpredictable ways.

1. Low threshold for investigation in diabetics, elderly, immunosuppressed, and neurologically impaired patients
2. Never attribute new symptoms to a known diagnosis without actively excluding something new
3. Absence of pain does NOT mean absence of pathology in neuropathic patients
4. Absence of fever does NOT mean absence of infection in immunosuppressed or elderly patients
5. Treat the patient, not the previous label — the "somatiser" and the "frequent flyer" can also have a real emergency

---

---

Juvenile Idiopathic Arthritis (JIA)

What Is JIA?

Arthritis of unknown aetiology, onset before 16 years of age, lasting at least 6 weeks, after exclusion of other diagnoses.

---

Epidemiology

• Prevalence: approximately 1 in 1,000 children
• Onset: before age 16 (by definition)
• Up to 50% of children have persistently active disease after 10 years
• JIA is the most common systemic disease associated with childhood anterior uveitis

---

ILAR Classification: 7 Subtypes

---

1. OLIGOARTICULAR JIA (Most Common — 40–50%)

• Persistent oligoarticular: Remains ≤4 joints for entire disease course. Uveitis risk: 16%
• Extended oligoarticular: Involves >4 joints after the first 6 months. Uveitis risk: 25% (higher)

• Most likely to develop asymptomatic anterior uveitis (the silent blinding complication — all oligoarticular JIA patients need slit-lamp screening)
• Leg length discrepancy (affected knee grows faster due to hyperaemia)
• Joint swelling is often painless
• Good functional prognosis if uveitis is caught early

---

2. POLYARTICULAR JIA — RF NEGATIVE (20–35%)

• Systemic features (fever, rash) may occur but are milder than systemic JIA
• Cervical spine involvement can cause atlantoaxial subluxation (important pre-anaesthesia)
• Uveitis in 4–10%
• More joints = more disability risk

---

3. POLYARTICULAR JIA — RF POSITIVE (<10%)

• Closest to adult RA — erosive, destructive disease
• Rheumatoid nodules (non-tender subcutaneous nodules on bony prominences, extensor surfaces)
• Worst functional prognosis among all JIA subtypes
• Anti-CCP antibodies often positive (same as adult RA)
• Uveitis very rare (2%)

---

4. SYSTEMIC JIA — Still's Disease (5–15%)

1. Evanescent (fleeting) erythematous maculopapular rash — salmon-pink, appears with fever spikes, disappears within hours
2. Generalised lymphadenopathy
3. Hepatomegaly and/or splenomegaly
4. Serositis (pericarditis, pleuritis, peritonitis)

• Fever pattern is characteristic: quotidian spikes (one or two daily fever spikes to >39°C, returning to normal or subnormal)
• Rash appears DURING fever spike — parents often cannot show it to the doctor
• Arthritis may begin months after systemic features
• Uveitis is rare (1%) in systemic JIA
• Most feared complication: Macrophage Activation Syndrome (MAS) — cytokine storm, disseminated intravascular coagulation, haemophagocytosis; life-threatening; ferritin may exceed 500,000 ng/mL

---

5. ENTHESITIS-RELATED ARTHRITIS — ERA (10–15%)

1. Sacroiliitis / axial spine involvement
2. HLA-B27 positive
3. Onset in males >6 years
4. Symptomatic acute anterior uveitis (painful, red eye — unlike the silent uveitis of oligoarticular JIA)
5. First-degree relative with HLA-B27-associated disease (ankylosing spondylitis, IBD-related arthritis, reactive arthritis, acute anterior uveitis)

• Enthesitis = pain/tenderness at insertions of tendons/ligaments into bone (Achilles, plantar fascia, tibial tuberosity, iliac crest, patella)
• Tarsitis (diffuse swelling of foot/ankle complex) — characteristic
• Precursor to ankylosing spondylitis in some patients
• Uveitis: 7%, but this type IS symptomatic (painful, red eye) unlike oligoarticular type

---

6. PSORIATIC JIA (5–10%)

1. Dactylitis ("sausage digit" — diffuse swelling of an entire digit)
2. Nail pitting or onycholysis
3. Psoriasis in a first-degree relative

• Psoriasis may appear years after arthritis (in young children especially) — do not wait for skin disease to diagnose
• Dactylitis is highly characteristic
• Uveitis in ~10% (often silent)
• Asymmetric joint involvement

---

7. UNDIFFERENTIATED JIA (5%)

• Arthritis that does not meet criteria for any above subtype
• OR fulfils criteria for 2 or more subtypes simultaneously
• ANA positive ~30%, HLA-B27 ~25%
• Uveitis risk: ~11%

---

ILAR Classification Summary Table

---

Clinical Diagnosis of JIA

JIA is a clinical diagnosis of exclusion. There is no single diagnostic test.

---

Step 1: Core Diagnostic Criteria (ILAR)

---

Step 2: Clinical Signs to Elicit

Joint Signs

Specific Signs

---

Step 3: Investigations

Blood Tests

Imaging

Ophthalmology (MANDATORY)

Critical: JIA uveitis causes NO symptoms, NO redness, NO pain — it is detected ONLY on slit-lamp. A child with JIA and a white, quiet eye can be actively destroying their vision.

Synovial Fluid Analysis (if effusion present)

---

Step 4: Exclusion Criteria (what must be ruled out)

• Septic arthritis (fever + elevated WBC + joint culture)
• Reactive arthritis (post-infection — Chlamydia, Salmonella, Shigella, Yersinia)
• Lyme disease (endemic areas — Borrelia serology)
• Systemic Lupus Erythematosus (ANA pattern, anti-dsDNA, complement)
• Malignancy (leukaemia, neuroblastoma — bone pain, night pain, pancytopenia, LDH)
• Inflammatory bowel disease (associated arthritis — GI symptoms)
• Kawasaki disease (children <5 with fever + rash + lymphadenopathy)
• Viral arthritis (parvovirus B19, EBV, rubella — usually self-limiting)
• Haemophilia (haemarthrosis — clotting studies)
• Hypermobility syndrome (pain without true inflammation)

---

Uveitis in JIA — The Silent Danger

---

Quick Diagnostic Framework

Child <16 years + joint swelling/stiffness >6 weeks + unknown cause
│
├── SYSTEMIC FEATURES (fever, rash, organomegaly)?
│   → Systemic JIA (Still's disease)
│   → Check ferritin, watch for MAS
│
├── ≤4 JOINTS?
│   → Oligoarticular JIA
│   → Check ANA, urgently refer ophthalmology
│
├── ≥5 JOINTS?
│   → Check RF:
│       RF positive × 2 → Polyarticular RF+
│       RF negative → Polyarticular RF–
│
├── ENTHESITIS + HLA-B27 positive + male + older child?
│   → ERA
│   → Check sacroiliac joints (MRI)
│
├── PSORIASIS / dactylitis / nail changes?
│   → Psoriatic JIA
│
└── DOESN'T FIT ANY above?
    → Undifferentiated JIA
    → Re-classify as disease evolves

---

Key Points Summary

• Age limit: Onset must be before 16 years; duration ≥6 weeks
• 7 ILAR subtypes: Oligoarticular (most common), Polyarticular RF–, Polyarticular RF+, Systemic, ERA, Psoriatic, Undifferentiated
• No diagnostic test confirms JIA — it is clinical + exclusion
• Uveitis is the great silent danger, especially in oligoarticular + ANA+ girls
• Ferritin >10,000 → alarm for Macrophage Activation Syndrome (systemic JIA)
• HLA-B27 + enthesitis in older boys → ERA (future ankylosing spondylitis risk)
• Dactylitis → Psoriatic JIA
• Salmon rash + quotidian fever → Systemic JIA (Still's disease)

---